As of January 23, 2025, Xenetic Biosciences (XBIO) has a market cap of $6.662 million USD. According to our data, Xenetic Biosciences is ranked No.8977 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $6.66 M |
8.27%
|
Dec 31, 2024 | $6.15 M |
15.65%
|
Dec 29, 2023 | $5.32 M |
21.05%
|
Dec 30, 2022 | $4.40 M |
-77.91%
|
Dec 31, 2021 | $19.89 M |
-36.76%
|
Dec 31, 2020 | $31.46 M |
41.67%
|
Dec 31, 2019 | $22.21 M |
-92.68%
|
Dec 31, 2018 | $0.30 B |
-14.54%
|
Dec 29, 2017 | $0.36 B |
-55.37%
|
Dec 30, 2016 | $0.80 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Market Cap | = | XBIO Stock Price | * | XBIO Shares Outstanding |
= | $4.32 | * | 1.54 M | |
= | $6.66 M |